Michael J. Brennan, MD

Medical Director
The Pain Center of Fairfield
Fairfield, Connecticut
Associate Director, Chronic Pain and Recovery Center
Silver Hill Hospital
New Canaan, Connecticut

Dr. Michael J. Brennan received his medical degree at the State University of New York Downstate Medical Center, and completed a residency in physical medicine and rehabilitation at the New York Hospital-Cornell University Medical Center, where he served as chief resident. While at New York Hospital, Dr. Brennan also served as chief resident at the International Center for the Disabled in New York City. Dr. Brennan is a board certified physiatrist in private practice in Fairfield, Connecticut.

After completing his residency, Dr. Brennan was appointed to the faculty of New York Hospital and Cornell Medical College in the Department of Physical Medicine and Rehabilitation. He served as acting chief of the rehabilitation service in the Department of Neurology at Memorial Sloan-Kettering Cancer Center. After leaving Sloan-Kettering, Dr. Brennan became the medical director of the Rehabilitation Center of Fairfield County and Ahlbin Centers for Rehabilitation Medicine and chief of the section of physical medicine at Bridgeport Hospital in Bridgeport, Connecticut. He is currently a senior attending physician in the Department of Medicine at Bridgeport Hospital and consulting physician at St. Vincent’s Hospital in Bridgeport, Connecticut. He is associate director of the interdisciplinary chronic pain and addiction program at Silver Hill Hospital in New Canaan, Connecticut, which is designed to address the complex needs of patients suffering with chronic pain and substance misuse, addiction and behavioral disorders.

Dr. Brennan has special interests in the emerging role of pharmacogenomics, particularly as to the role of variability and vulnerability to opioid and adjuvant analgesics in individuals suffering with pain. He has recently published articles on opioids and pharmacogenomics opioid metabolism as well as articles concerning deleterious effects of opioids on the endocrine system. Dr. Brennan has a long-held interest in the management of pain as well as disability in patients suffering from the acute and long-term effects of musculoskeletal diseases, neurological disorders, cancer, and various cancer treatments. He has published over 40 scholarly articles, abstracts, and textbook chapters on the treatment of cancer and noncancer related disabilities including lymphedema and pain. He is a reviewer for several medical journals and has served as guest editor for the Journal of Musculoskeletal Rehabilitation and as online editor for Pain.com. Recently, Dr. Brennan was awarded the Dr. Elizabeth Narcessian Memorial Award from Kessler Institute, recognizing his commitment to the treatment of patients suffering from chronic pain.

Financial Disclosure
Dr. Michael Brennan has received honoraria related to speakers' bureau activities from Cephalon, Inc., Eli Lilly and Company, Endo Pharmaceuticals, Forest Laboratories, Inc., Merck & Co., Inc., Pfizer Inc., King Pharmaceuticals, Inc., and Purdue Pharma L.P., as well as formal advisory activities from Cephalon, Endo, Johnson & Johnson, Wyeth, King, and Purdue. He has received consultant fees from Cephalon, Endo, J & J, King, and Purdue.

Last modified: March 18, 2015